Topic · page 17 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 641–680 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

RMD Open26 Mar 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
Secondary analysis
Rheumatology (Oxford)26 Mar 2024
The worldwide prevalence of psoriatic arthritis—a systematic review and meta-analysis
Meta-analysis
Rheumatology (Oxford)22 Mar 2024
Unveiling the distinctive ossification patterns of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis using computed tomography three-dimensional reconstruction
Case-control study
RMD Open22 Mar 2024
Sex differences in cytokines and adipokines in obese patients with PsA and controls undergoing a weight loss intervention
Secondary analysis
Rheumatology (Oxford)20 Mar 2024
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy
Cohort study
Arthritis Res Ther16 Mar 2024
The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis
Meta-analysis
Rheumatology (Oxford)15 Mar 2024
16s RNA-based metagenomics reveal previously unreported gut microbiota associated with reactive arthritis and undifferentiated peripheral spondyloarthritis
Case-control study
J Rheumatol15 Mar 2024
Maximal Exercise Tolerance, Objective Trunk Strength, and Mobility Measurements in Axial Spondyloarthritis
Cross-sectional study
J Rheumatol15 Mar 2024
Defining the Minimal Important Change and Meaningful Change Value of the Disease Activity Index for Psoriatic Arthritis: A Chinese Longitudinal Study
Cohort study
Rheumatology (Oxford)15 Mar 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel
Guideline or statement
RMD Open14 Mar 2024
Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS)
Cohort study
Rheumatology (Oxford)13 Mar 2024
Flare prediction after tapering the dose of tumour necrosis factor inhibitors in patients with axial spondyloarthritis: a nationwide cohort study
Diagnostic or prognostic study
Ann Rheum Dis12 Mar 2024
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Cohort study
Rheumatology (Oxford)9 Mar 2024
Characteristics associated with patient-reported treatment success in psoriatic arthritis
Cross-sectional study
RMD Open4 Mar 2024
Learning imaging in axial spondyloarthritis: more than just a matter of experience
Diagnostic or prognostic study
Arthritis Rheumatol4 Mar 2024
Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis
Mechanistic study
Semin Arthritis Rheum2 Mar 2024
Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort
Cohort study
RMD Open29 Feb 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
Cohort study
RMD Open27 Feb 2024
Window of opportunity in psoriatic arthritis: the earlier the better?
Cohort study
Arthritis Rheumatol25 Feb 2024
Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Cohort study
Clin Exp Rheumatol24 Feb 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry
Cohort study
RMD Open23 Feb 2024
Exploring radiographic patterns of the cervical spine, including zygapophyseal joints, in axial spondyloarthritis
Cross-sectional study
Rheumatology (Oxford)23 Feb 2024
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings
Cohort study
RMD Open22 Feb 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Randomized controlled trial
Rheumatology (Oxford)16 Feb 2024
Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies
Meta-analysis
J Rheumatol15 Feb 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)
Secondary analysis
J Rheumatol15 Feb 2024
Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort
Cohort study
J Rheumatol15 Feb 2024
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review
Meta-analysis
J Rheumatol15 Feb 2024
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA)
Cohort study
RMD Open15 Feb 2024
Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs
Cross-sectional study
Arthritis Res Ther15 Feb 2024
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis
Meta-analysis
Ann Rheum Dis15 Feb 2024
CD_99 G1 neutrophils modulate osteogenic differentiation of mesenchymal stem cells in the pathological process of ankylosing spondylitis
Mechanistic study
RMD Open13 Feb 2024
Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis
Research article
Arthritis Res Ther12 Feb 2024
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
Secondary analysis
Rheumatology (Oxford)10 Feb 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis
Secondary analysis
Rheumatology (Oxford)8 Feb 2024
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials
Secondary analysis
Semin Arthritis Rheum7 Feb 2024
Relationship between spinal structural damage and sagittal balance in axial spondyloarthritis: Is the thoracic spine the starting point?
Cross-sectional study
Rheumatology (Oxford)6 Feb 2024
Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials
Meta-analysis
Semin Arthritis Rheum3 Feb 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee region
Guideline or statement
Semin Arthritis Rheum2 Feb 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis
Guideline or statement

All 1,039 Briefs in ExploreShowing Briefs 641–680 of 1,039, newest first